COVID-19 treatment
-
June 2, 2022
Study explores positioning options to improve COVID mortality
Vanderbilt researchers found that prone positioning of patients with COVID-19-related hypoxemia not on mechanical ventilation offered no observed clinical benefit among these patients. -
May 16, 2022
Multiple outpatient treatment options for COVID-19, including Paxlovid™
-
May 10, 2022
Resistance to COVID-19 drug detected in lab study
Vanderbilt research shows that the virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. -
April 6, 2022
Major grant renewal to provide five more years of support for VICTR
Vanderbilt University Medical Center has competed successfully for a third renewal of its Clinical and Translational Science Award by the National Institutes of Health. -
March 31, 2022
Crowe receives national award for COVID antibody research
Vanderbilt's James Crowe Jr., MD, and Michel Nussenzweig, MD, PhD, of The Rockefeller University, have been jointly awarded the 2022 Harrington Prize for Innovation in Medicine for “groundbreaking work” that enabled the use of human antibodies to treat COVID-19. -
March 30, 2022
Uncharted days of the COVID-19 pandemic strengthen the Vanderbilt Vaccine Research Program team.
“There’s something about having a band of brothers, where you’re all focused on the same thing, and your noses are all pointed in the same direction." -
March 30, 2022
Team helps patients battle post-COVID cognitive issues
Jane Stories is one of many COVID-19 patients still plagued by debilitating symptoms that include achy muscles, anxiety, depression, panic attacks and cognitive impairment.